Emerging therapeutic advancements in pancreatic cancer: a contemporary review
{{output}}
The escalating global burden of pancreatic ductal adenocarcinoma (PDAC) is imposing a critical health burden as a major cause of cancer-related mortality. Survival rates are low due to late-stage diagnosis and complex tumor microenvironments. The review discus... ...
